Adenosine-5'-Diphosphate Trilithium Salt Hydrate, MP Biomedicals™

Catalog No.	Quantity
MP021502615	500 mg

Catalog No. MP021502615 Supplier MP Biomedicals, Inc Supplier No. 02150261.5

Description

Adenosine-5'-Diphosphate Trilithium Salt Hydrate, MP Biomedicals is a lithium salt formulation of the essential metabolic compound ADP.

Adenosine 5′-diphosphate has been used to study the release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD+) in the rat brain. Adenosine 5′-diphosphate has also been used to compare prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome.

Specifications

Chemical Identifiers

• CAS: 31008-64-7
• Molecular Formula: C10H12Li3N5O10P2
• Molecular Weight (g/mol): 445.00
• MDL Number: MFCD00065469
• InChI Key: LZGPPAHUZSOGHJ-DJXXCMMGNA-K
• Synonym: adenosine-5'-diphosphate trilithium salt, adenosine 5'-trihydrogen diphosphate , trilithium salt, adp-li3, trilithium 1+ adenosine 5'-diphosphate, adenosine 5'-diphosphate trilithium salt, adenosine 5'-diphosphate,trilithium salt, adenosine-5'-diphosphate, trilithium salt, trilithium 1+ ion adenosine 5'-diphosphate, adenosine 5'-diphosphoric acid trilithium salt, adenosine-5'-diphosphate,trilithium salt
• PubChem CID: 56841973
• IUPAC Name: trilithium(1+) ({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate
• SMILES: [Li+].[Li+].[Li+].NC1=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1

• Refractive Index: ∼1.90 (Predicted) (Lit.)
• Quantity: 500 mg
• Formula Weight: 445 (anhydrous)
• Percent Purity: ≥96%
• Physical Form: Powder

Safety and Handling

Recommended Storage

Store at –20°C

WARNING: Reproductive Harm - www.P65Warnings.ca.gov